BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.05B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$801M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$384M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$339M |
| 5 |
Microsoft
MSFT
|
+$316M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$205M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
+$121M |
| 3 |
Thomson Reuters
TRI
|
+$106M |
| 4 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$100M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$96.1M |
Sector Composition
| 1 | Technology | 11.63% |
| 2 | Financials | 10.98% |
| 3 | Healthcare | 9.86% |
| 4 | Communication Services | 9.83% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARGO
2001
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $266K | ﹤0.01% |
4,982
-272
| -5% | -$14.5K |
|
2002
Movado Group
MOV
$442M
| $265K | ﹤0.01% |
9,474
+2,857
| +43% | +$80K |
|
|
APU
2003
DELISTED
AmeriGas Partners, L.P.
APU
| $265K | ﹤0.01% |
5,900
+1,900
| +48% | +$85.4K |
|
|
GCP
2004
DELISTED
GCP Applied Technologies Inc.
GCP
| $265K | ﹤0.01% |
8,632
-1,034
| -11% | -$31.7K |
|
2005
Alamos Gold
AGI
$14.1B
| $265K | ﹤0.01% |
70,051
+6,938
| +11% | +$26.2K |
|
|
GOLD
2006
DELISTED
Randgold Resources Ltd
GOLD
| $265K | ﹤0.01% |
2,710
-3,829
| -59% | -$374K |
|
2007
Pegasystems
PEGA
$10.1B
| $263K | ﹤0.01% |
9,136
-964
| -10% | -$27.8K |
|
2008
Cross Country Healthcare
CCRN
$431M
| $263K | ﹤0.01% |
18,500
+8,502
| +85% | +$121K |
|
2009
Kosmos Energy
KOS
$808M
| $263K | ﹤0.01% |
33,038
+211
| +0.6% | +$1.68K |
|
2010
DXP Enterprises
DXPE
$1.84B
| $263K | ﹤0.01% |
8,346
+2,658
| +47% | +$83.7K |
|
2011
Groupon
GRPN
$911M
| $262K | ﹤0.01% |
2,524
-70
| -3% | -$7.28K |
|
|
WW
2012
DELISTED
WW International
WW
| $262K | ﹤0.01% |
6,017
-1,117
| -16% | -$48.6K |
|
|
PMT
2013
PennyMac Mortgage Investment
PMT
$1.07B
| $262K | ﹤0.01% |
15,045
-139
| -0.9% | -$2.42K |
|
2014
Insmed
INSM
$30.3B
| $261K | ﹤0.01% |
8,365
+867
| +12% | +$27.1K |
|
|
ENV
2015
DELISTED
ENVESTNET, INC.
ENV
| $260K | ﹤0.01% |
5,105
-46
| -0.9% | -$2.35K |
|
|
PGNX
2016
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $260K | ﹤0.01% |
35,323
+14,758
| +72% | +$109K |
|
2017
Lantheus
LNTH
$3.52B
| $259K | ﹤0.01% |
14,565
+6,274
| +76% | +$112K |
|
2018
Galicia Financial Group
GGAL
$4.69B
| $259K | ﹤0.01% |
5,021
-626
| -11% | -$32.3K |
|
|
PPBI
2019
DELISTED
Pacific Premier Bancorp
PPBI
| $259K | ﹤0.01% |
6,853
+2,830
| +70% | +$107K |
|
|
WSR
2020
Whitestone REIT
WSR
$660M
| $259K | ﹤0.01% |
19,815
+14,835
| +298% | +$194K |
|
|
HRG
2021
DELISTED
HRG Group, Inc.
HRG
| $257K | ﹤0.01% |
16,485
-198,127
| -92% | -$3.09M |
|
2022
SPDR Bloomberg Convertible Securities ETF
CWB
$4.53B
| $257K | ﹤0.01% |
5,035
-1,158
| -19% | -$59.1K |
|
|
ECHO
2023
DELISTED
Echo Global Logistics, Inc.
ECHO
| $256K | ﹤0.01% |
13,555
+5,456
| +67% | +$103K |
|
2024
Myers Industries
MYE
$598M
| $255K | ﹤0.01% |
12,176
+3,539
| +41% | +$74.1K |
|
2025
Ironwood Pharmaceuticals
IRWD
$208M
| $255K | ﹤0.01% |
19,282
-1,071
| -5% | -$14.1K |
|